1. Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer
   Laura Zanotti et al, 2017, The Laryngoscope CrossRef
2. Peptide ligand-modified nanomedicines for targeting cells at the tumor microenvironment
   Ayelet David, 2017, Advanced Drug Delivery Reviews CrossRef
3. Peptide-Based Nanocarriers for Cancer Therapy
   Guoqing Wei et al, 2018, Small Methods CrossRef
4. Annexin A1 regulates EGFR activity and alters EGFR-containing tumour-derived exosomes in head and neck cancers
   N. Raulf et al, 2018, European Journal of Cancer CrossRef
5. Peptide-Based Multifunctional Nanomaterials for Tumor Imaging and Therapy
   Chi Zhang et al, 2018, Adv. Funct. Mater. CrossRef
6. MAGE-A expression in oral and laryngeal leukoplakia predicts malignant transformation
   Christoph A. Baran et al, 2019, Mod Pathol CrossRef
7. Principles in the design of ligand-targeted cancer therapeutics and imaging agents
   Madduri Srinivasarao et al, 2015, Nat Rev Drug Discov CrossRef
8. The increase of oncogenic miRNA expression in tongue carcinogenesis of a mouse model
   Yu-Yu Kao et al, 2015, Oral Oncology CrossRef
9. Quantitative Immunoexpression of EGFR in Oral Potentially Malignant Disorders: Oral Leukoplakia and Oral Submucous Fibrosis
   Naga Jyothi Meka et al, 2015, J Dent Res Dent Clin Dent Prospects CrossRef
10. Gold nanorods reflectance discriminate benign from malignant oral lesions
    Abraham Hirshberg et al, 2017, Nanomedicine: Nanotechnology, Biology and Medicine CrossRef
11. Malignant transformation of oral leukoplakia is associated with macrophage polarization
    Manuel Weber et al, 2020, J Transl Med CrossRef
12. World Workshop on Oral Medicine VII: Prognostic biomarkers in oral leukoplakia and proliferative verrucous leukoplakia—A systematic review of retrospective studies
    Antonio Celentano et al, 2020, Oral Dis CrossRef
13. Epithelial‐to‐mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities
    Zihang Ling et al, 2020, Int. J. Cancer CrossRef
14. Changes in Epidermal Growth Factor Receptor Gene Copy Number during Oral Carcinogenesis
    Timothy Bates et al, 2016, Cancer Epidemiol Biomarkers Prev CrossRef
15. Tissue biomarkers for predicting the risk of oral cancer in patients diagnosed with oral leukoplakia: A systematic review
    Luis Monteiro et al, 2021, Oral Dis CrossRef
16. Bio-vehicles of cytotoxic drugs for delivery to tumor specific targets for cancer precision therapy
    Layla Al-mansoori et al, 2021, Biomedicine & Pharmacotherapy CrossRef
17. Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: Current knowledge and future implications
    Nikolaos G. Nikitakis et al, 2018, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology CrossRef
18. Molecular Crosstalk between the Immunological Mechanism of the Tumor Microenvironment and Epithelial–Mesenchymal Transition in Oral Cancer
    Kaviyarasi Renu et al, 2022, Vaccines CrossRef
19. Single‐cell transcriptomics dissects premalignant progression in proliferative verrucous leukoplakia
    Liang Zhong et al, 2022, Oral Diseases CrossRef
20. Escape from Cellular Senescence Is Associated with Chromosomal Instability in Oral Pre-Malignancy
    Stephen S. Prime et al, 2023, Biology CrossRef
21. Nuclear Epidermal Growth Factor Receptor Overexpression as a Survival Predictor in Oral Squamous Cell Carcinoma
    Marko Tarle et al, 2023, IJMS CrossRef
22. Comparison of EGFR (Epithelial Growth Factor Receptor) expression as a protein marker in Oral Erosive & Reticular Lichen Planus and Oral Epithelial Dysplasia
    forooz keshani et al, 2023, J Res Dent Sci CrossRef
23. Immunohistochemical Expression of Epidermal Growth Factor Receptor (EGFR) in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders
    Razia Aamir et al, 2024 CrossRef
24. Tumor-specific Peptide Probes and the Applications in Bioimaging
    Bo Wang et al, 2024, Acta Chimica Sinica CrossRef